Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

The prevalence of nonlinearity and detection of ecological breakpoints across a land use gradient in streams.

D'Amario SC, Rearick DC, Fasching C, Kembel SW, Porter-Goff E, Spooner DE, Williams CJ, Wilson HF, Xenopoulos MA.

Sci Rep. 2019 Mar 7;9(1):3878. doi: 10.1038/s41598-019-40349-4.

2.

Telomere length measurement as a clinical biomarker of aging and disease.

Fasching CL.

Crit Rev Clin Lab Sci. 2018 Nov;55(7):443-465. doi: 10.1080/10408363.2018.1504274. Epub 2018 Sep 28. Review.

PMID:
30265166
3.

The use of mid-infrared spectrometry to estimate the ration composition of lactating dairy cows.

Klaffenböck M, Steinwidder A, Fasching C, Terler G, Gruber L, Mészáros G, Sölkner J.

J Dairy Sci. 2017 Jul;100(7):5411-5421. doi: 10.3168/jds.2016-12189. Epub 2017 May 17.

4.

Hydrology controls dissolved organic matter export and composition in an Alpine stream and its hyporheic zone.

Fasching C, Ulseth AJ, Schelker J, Steniczka G, Battin TJ.

Limnol Oceanogr. 2016 Mar;61(2):558-571. Epub 2015 Dec 1.

5.

Top3-Rmi1 dissolve Rad51-mediated D loops by a topoisomerase-based mechanism.

Fasching CL, Cejka P, Kowalczykowski SC, Heyer WD.

Mol Cell. 2015 Feb 19;57(4):595-606. doi: 10.1016/j.molcel.2015.01.022.

6.

Microbial degradation of terrigenous dissolved organic matter and potential consequences for carbon cycling in brown-water streams.

Fasching C, Behounek B, Singer GA, Battin TJ.

Sci Rep. 2014 May 15;4:4981. doi: 10.1038/srep04981.

7.

Rare but active taxa contribute to community dynamics of benthic biofilms in glacier-fed streams.

Wilhelm L, Besemer K, Fasching C, Urich T, Singer GA, Quince C, Battin TJ.

Environ Microbiol. 2014 Aug;16(8):2514-24. doi: 10.1111/1462-2920.12392. Epub 2014 Feb 18.

PMID:
24428193
8.

A conserved sequence extending motif III of the motor domain in the Snf2-family DNA translocase Rad54 is critical for ATPase activity.

Zhang XP, Janke R, Kingsley J, Luo J, Fasching C, Ehmsen KT, Heyer WD.

PLoS One. 2013 Dec 16;8(12):e82184. doi: 10.1371/journal.pone.0082184. eCollection 2013. Erratum in: PLoS One. 2014;9(6):e101094.

9.

Pneumococcal IgA1 protease subverts specific protection by human IgA1.

Janoff EN, Rubins JB, Fasching C, Charboneau D, Rahkola JT, Plaut AG, Weiser JN.

Mucosal Immunol. 2014 Mar;7(2):249-56. doi: 10.1038/mi.2013.41. Epub 2013 Jul 3.

10.

Microbial biodiversity in glacier-fed streams.

Wilhelm L, Singer GA, Fasching C, Battin TJ, Besemer K.

ISME J. 2013 Aug;7(8):1651-60. doi: 10.1038/ismej.2013.44. Epub 2013 Mar 14.

11.

Short communication: HIV type 1 escapes inactivation by saliva via rapid escape into oral epithelial cells.

Dietrich EA, Gebhard KH, Fasching CE, Giacaman RA, Kappes JC, Ross KF, Herzberg MC.

AIDS Res Hum Retroviruses. 2012 Dec;28(12):1574-8. doi: 10.1089/AID.2011.0069. Epub 2012 Jan 17.

12.

Quantitation of methylmalonic acid in plasma using liquid chromatography-tandem mass spectrometry.

Fasching C, Singh J.

Methods Mol Biol. 2010;603:371-8. doi: 10.1007/978-1-60761-459-3_36.

PMID:
20077089
13.

Oral keratinocytes support non-replicative infection and transfer of harbored HIV-1 to permissive cells.

Vacharaksa A, Asrani AC, Gebhard KH, Fasching CE, Giacaman RA, Janoff EN, Ross KF, Herzberg MC.

Retrovirology. 2008 Jul 17;5:66. doi: 10.1186/1742-4690-5-66.

14.

DNA damage induces alternative lengthening of telomeres (ALT) associated promyelocytic leukemia bodies that preferentially associate with linear telomeric DNA.

Fasching CL, Neumann AA, Muntoni A, Yeager TR, Reddel RR.

Cancer Res. 2007 Aug 1;67(15):7072-7. Epub 2007 Jul 24.

15.

Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae.

Fasching CE, Grossman T, Corthésy B, Plaut AG, Weiser JN, Janoff EN.

Infect Immun. 2007 Apr;75(4):1801-10. Epub 2007 Jan 29.

17.

Human T lymphotropic virus type II infection and humoral responses to pneumococcal polysaccharide and tetanus toxoid vaccines.

Jarvis GA, Janoff EN, Cheng H, Devita D, Fasching C, McCulloch CE, Murphy EL.

J Infect Dis. 2005 Apr 15;191(8):1239-44. Epub 2005 Mar 14.

PMID:
15776369
18.

Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway.

King SJ, Hippe KR, Gould JM, Bae D, Peterson S, Cline RT, Fasching C, Janoff EN, Weiser JN.

Mol Microbiol. 2004 Oct;54(1):159-71.

19.

Pedigree analysis and descriptive investigation of three classic phenotypes associated with Holt-Oram syndrome.

Lehner R, Goharkhay N, Tringler B, Fasching C, Hengstschläger M.

J Reprod Med. 2003 Mar;48(3):153-9. Review.

PMID:
12698771
20.

Antibody-enhanced pneumococcal adherence requires IgA1 protease.

Weiser JN, Bae D, Fasching C, Scamurra RW, Ratner AJ, Janoff EN.

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4215-20. Epub 2003 Mar 17.

21.

Induction of functional secretory IgA responses in breast milk, by pneumococcal capsular polysaccharides.

Finn A, Zhang Q, Seymour L, Fasching C, Pettitt E, Janoff EN.

J Infect Dis. 2002 Nov 15;186(10):1422-9. Epub 2002 Oct 23.

PMID:
12404157
22.

Cys(9), Cys(104) and Cys(207) of simian virus 40 Vp1 are essential for infectious virion formation in CV-1 cells.

Gharakhanian E, Fasching CL, Orlando SJ, Perez AR.

J Gen Virol. 2001 Aug;82(Pt 8):1935-9.

PMID:
11458000
23.

Pictures in Molecular Medicine: Telomeres copying telomeres in human cells.

Neumann A, Fasching C.

Trends Mol Med. 2001 Apr;7(4):184. No abstract available.

PMID:
11286945
24.

Novel molecular variants of allele I of the Escherichia coli P fimbrial adhesin gene papG.

Johnson JR, Stell AL, Kaster N, Fasching C, O'Bryan TT.

Infect Immun. 2001 Apr;69(4):2318-27.

25.

Telomere maintenance by recombination in human cells.

Dunham MA, Neumann AA, Fasching CL, Reddel RR.

Nat Genet. 2000 Dec;26(4):447-50.

PMID:
11101843
26.

Evidence of commonality between canine and human extraintestinal pathogenic Escherichia coli strains that express papG allele III.

Johnson JR, O'Bryan TT, Low DA, Ling G, Delavari P, Fasching C, Russo TA, Carlino U, Stell AL.

Infect Immun. 2000 Jun;68(6):3327-36.

27.

Analysis of the F antigen-specific papA alleles of extraintestinal pathogenic Escherichia coli using a novel multiplex PCR-based assay.

Johnson JR, Stell AL, Scheutz F, O'Bryan TT, Russo TA, Carlino UB, Fasching C, Kavle J, Van Dijk L, Gaastra W.

Infect Immun. 2000 Mar;68(3):1587-99. Erratum in: Infect Immun 2000 Dec;68(12):7215.

28.

Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes.

Janoff EN, Fasching C, Orenstein JM, Rubins JB, Opstad NL, Dalmasso AP.

J Clin Invest. 1999 Oct;104(8):1139-47.

29.

Pneumococcal vaccination in HIV-1-infected adults in Uganda: humoral response and two vaccine failures.

French N, Gilks CF, Mujugira A, Fasching C, O'Brien J, Janoff EN.

AIDS. 1998 Sep 10;12(13):1683-9.

PMID:
9764789
30.

Septic siblings with pneumonia due to penicillin-resistant Streptococcus pneumoniae.

Williams DN, Fasching C, Janoff EN.

Clin Infect Dis. 1998 May;26(5):1230-1. No abstract available.

PMID:
9597259
31.

Loss of suppressor loci on chromosomes 11 and 14 may be required for radiation-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.

Mendonca MS, Howard K, Fasching CL, Farrington DL, Desmond LA, Stanbridge EJ, Redpath JL.

Radiat Res. 1998 Mar;149(3):246-55.

PMID:
9496887
32.

Nitric oxide production during Vibrio cholerae infection.

Janoff EN, Hayakawa H, Taylor DN, Fasching CE, Kenner JR, Jaimes E, Raij L.

Am J Physiol. 1997 Nov;273(5):G1160-7. doi: 10.1152/ajpgi.1997.273.5.G1160.

PMID:
9374715
33.

Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte line HaCaT.

Boukamp P, Popp S, Altmeyer S, Hülsen A, Fasching C, Cremer T, Fusenig NE.

Genes Chromosomes Cancer. 1997 Aug;19(4):201-14.

PMID:
9258654
34.

Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.

Wahl SM, Worley P, Jin W, McNeely TB, Eisenberg S, Fasching C, Orenstein JM, Janoff EN.

Am J Pathol. 1997 Apr;150(4):1275-84.

35.
36.

Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells.

Plattner R, Anderson MJ, Sato KY, Fasching CL, Der CJ, Stanbridge EJ.

Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6665-70.

37.

Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia.

Rubins JB, Charboneau D, Fasching C, Berry AM, Paton JC, Alexander JE, Andrew PW, Mitchell TJ, Janoff EN.

Am J Respir Crit Care Med. 1996 Apr;153(4 Pt 1):1339-46.

PMID:
8616564
38.

Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and additional chromosome loss.

Boukamp P, Peter W, Pascheberg U, Altmeier S, Fasching C, Stanbridge EJ, Fusenig NE.

Oncogene. 1995 Sep 7;11(5):961-9.

PMID:
7675455
39.

Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.

Mendonca MS, Fasching CL, Srivatsan ES, Stanbridge EJ, Redpath JL.

Radiat Res. 1995 Jul;143(1):34-44.

PMID:
7597142
41.

Evidence that wild-type TP53, and not genes on either chromosome 1 or 11, controls the tumorigenic phenotype of the human fibrosarcoma HT1080.

Anderson MJ, Casey G, Fasching CL, Stanbridge EJ.

Genes Chromosomes Cancer. 1994 Apr;9(4):266-81.

PMID:
7519049
42.

Chromosome 13 transfer provides evidence for regulation of RB1 protein expression.

Anderson MJ, Fasching CL, Xu HJ, Benedict WF, Stanbridge EJ.

Genes Chromosomes Cancer. 1994 Apr;9(4):251-60.

PMID:
7519047
43.

Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell lines.

Sato KY, Polakis PG, Haubruck H, Fasching CL, McCormick F, Stanbridge EJ.

Cancer Res. 1994 Jan 15;54(2):552-9.

44.

Activity of twenty-one antimicrobial agents including l-ofloxacin against quinolone-sensitive and -resistant, and methicillin-sensitive and -resistant Staphylococcus aureus.

Peterson LR, Cooper I, Willard KE, Fasching CE, Sinn LM, Shanholtzer CJ, Gerding DN.

Chemotherapy. 1994 Jan-Feb;40(1):21-5.

PMID:
8306811
45.

Functional evidence for a breast cancer growth suppressor gene on chromosome 17.

Casey G, Plummer S, Hoeltge G, Scanlon D, Fasching C, Stanbridge EJ.

Hum Mol Genet. 1993 Nov;2(11):1921-7.

PMID:
8281156
46.

GyrA sequence analysis of Staphylococcus aureus and methicillin-resistant S. aureus strains selected, in vitro, for high-level ciprofloxacin resistance.

Peterson LR, Willard KE, Sinn LM, Fasching CE, Gerding DN.

Diagn Microbiol Infect Dis. 1993 Aug-Sep;17(2):97-101.

PMID:
7902228
47.

Medical technologists using molecular epidemiology as part of the infection control team.

Peterson LR, Petzel RA, Clabots CR, Fasching CE, Gerding DN.

Diagn Microbiol Infect Dis. 1993 May-Jun;16(4):303-11.

PMID:
8495585
49.
50.

gyrA mutations in ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus from Indiana, Minnesota, and Tennessee.

Fasching CE, Tenover FC, Slama TG, Fisher LM, Sreedharan S, Oram M, Willard K, Sinn LM, Gerding DN, Peterson LR.

J Infect Dis. 1991 Nov;164(5):976-9.

PMID:
1658161

Supplemental Content

Loading ...
Support Center